全文获取类型
收费全文 | 1708篇 |
免费 | 192篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 45篇 |
妇产科学 | 55篇 |
基础医学 | 249篇 |
口腔科学 | 41篇 |
临床医学 | 127篇 |
内科学 | 431篇 |
皮肤病学 | 37篇 |
神经病学 | 164篇 |
特种医学 | 163篇 |
外科学 | 100篇 |
综合类 | 109篇 |
一般理论 | 5篇 |
预防医学 | 133篇 |
眼科学 | 2篇 |
药学 | 147篇 |
1篇 | |
中国医学 | 1篇 |
肿瘤学 | 95篇 |
出版年
2021年 | 14篇 |
2020年 | 11篇 |
2019年 | 23篇 |
2018年 | 19篇 |
2017年 | 21篇 |
2016年 | 23篇 |
2015年 | 27篇 |
2014年 | 42篇 |
2013年 | 50篇 |
2012年 | 60篇 |
2011年 | 52篇 |
2010年 | 47篇 |
2009年 | 54篇 |
2008年 | 53篇 |
2007年 | 79篇 |
2006年 | 88篇 |
2005年 | 64篇 |
2004年 | 62篇 |
2003年 | 65篇 |
2002年 | 47篇 |
2001年 | 56篇 |
2000年 | 57篇 |
1999年 | 47篇 |
1998年 | 36篇 |
1997年 | 64篇 |
1996年 | 58篇 |
1995年 | 44篇 |
1994年 | 48篇 |
1993年 | 46篇 |
1992年 | 47篇 |
1991年 | 35篇 |
1990年 | 41篇 |
1989年 | 38篇 |
1988年 | 37篇 |
1987年 | 30篇 |
1986年 | 28篇 |
1985年 | 30篇 |
1984年 | 22篇 |
1983年 | 29篇 |
1982年 | 27篇 |
1981年 | 19篇 |
1980年 | 13篇 |
1979年 | 16篇 |
1978年 | 15篇 |
1977年 | 12篇 |
1976年 | 20篇 |
1975年 | 18篇 |
1974年 | 9篇 |
1972年 | 7篇 |
1971年 | 9篇 |
排序方式: 共有1908条查询结果,搜索用时 31 毫秒
1.
2.
3.
Simon Bell Andrew J McLachlan Parisa Aslani Paula Whitehead Timothy F Chen 《Australia and New Zealand Health Policy》2005,2(1):29
The objective of this systematic review was to evaluate the impact of pharmacist delivered community-based services to optimise the use of medications for mental illness. Twenty-two controlled (randomised and non-randomised) studies of pharmacists' interventions in community and residential aged care settings identified in international scientific literature were included for review. Papers were assessed for study design, service recipient, country of origin, intervention type, number of participating pharmacists, methodological quality and outcome measurement. Three studies showed that pharmacists' medication counselling and treatment monitoring can improve adherence to antidepressant medications among those commencing treatment when calculated using an intention-to-treat analysis. Four trials demonstrated that pharmacist conducted medication reviews may reduce the number of potentially inappropriate medications prescribed to those at high risk of medication misadventure. The results of this review provide some evidence that pharmacists can contribute to optimising the use of medications for mental illness in the community setting. However, more well designed studies are needed to assess the impact of pharmacists as members of community mental health teams and as providers of comprehensive medicines information to people with schizophrenia and bipolar disorder 相似文献
4.
5.
Desferrioxamine (DFO) metabolism and its pharmacokinetics were studied in a swine model using high-performance liquid chromatography. DFO and three iron-binding metabolites occurred in plasma. Interindividual differences in pharmacokinetics and metabolism were observed. Urine analysis in 4 pigs showed three iron-binding metabolites. The mean percent dose excreted in urine in the form of the parent drug was 45 +/- 10% and 10 +/- 2% (means +/- SD) in the form of metabolites. Of the total amount of the parent drug infused, 3 h after initiation, 87% was in the form of DFO, whereas 13% was present as the DFO-iron III complex which represented 45 mg of urinary iron elimination. The described DFO infusion protocol provides for sufficient DFO to chelate significant amounts of ferric iron in excess of normal levels, thus allowing experimental studies of iron chelation in a variety of disease states. 相似文献
6.
De Leo V; Morgante G; Lanzetta D; D'Antona D; Bertieri RS 《Human reproduction (Oxford, England)》1997,12(2):357-360
We report the results of administration of danazol after suspension of
gonadotrophin-releasing hormone analogue (GnRHa) therapy for uterine
myomas. A total of 21 women with uterine myomas was treated with 100 mg
danazol for 6 months after GnRHa therapy. Uterine volume and endocrine
status were monitored monthly by ultrasound and assay of plasma
gonadotrophins, oestradiol and progesterone. The results show a rebound of
uterine volume about 30% less than in controls at the end of danazol
therapy. Menstrual cyclicity returned after 65 +/- 3 days in 16 subjects
and five patients remained amenorrhoeic. Hormone assays confirmed renewed
ovarian function in the women whose menstrual periods returned. Bone
mineral content was substantially reduced during GnRHa treatment but
improved significantly during danazol therapy even in the women who
remained amenorrhoeic. These results show the utility of danazol in
prolonging the therapeutic effects of GnRHa. The mechanism by which danazol
inhibits rebound of uterine volume may be due to its antiprogesterone
effects on uterine myomas.
相似文献
7.
R R Newbold P H Jellinck M Metzler J A McLachlan 《Teratogenesis, carcinogenesis, and mutagenesis》1991,11(5):267-278
Outbred CD-1 mice treated for 1 or 4 days with 1 mg/kg of diethylstilbestrol (DES) at various ages after birth were examined for histochemical localization of peroxidase in the uterine epithelium. Peroxidase activity in uterine extracts was also measured by a radiometric assay and the conversion of [3H]DES to [3H]Z,Z-diensestrol (Z,Z-DIES). While no peroxidase activity was detected by a histochemical method in uterine epithelium from untreated 5-day old mice, the enzyme was apparent in mice treated for 4 days with DES; uterine eosinophils were absent at this age. By day 9, DES-induced staining for peroxidase in uterine epithelial cells and the number of uterine eosinophils had increased significantly. In addition, at this age, the biochemical assays for uterine peroxidase were sensitive enough to show that DES is converted to Z,Z-DIES and that [3H]estradiol gives rise to 3H2O and water-soluble radioactive metabolites. The peroxidase response to DES, determined by both histochemical and biochemical methods, increased with the age of the immature mice. These data indicate that the neonatal uterus, although deficient in eosinophils, demonstrates a peroxidase response to estrogen and that this response is localized primarily in the luminal epithelium. The role of this DES-induced peroxidase activity in converting DES to activated metabolites that may cause cell damage is discussed. 相似文献
8.
9.
Stuart J. McLachlan John C. Francisco Joseph R. Pernicone Anton N. Hasso 《Journal of magnetic resonance imaging : JMRI》1994,4(3):405-411
A phase III multicenter study was conducted in 89 patients with known intracranial vascular lesions to evaluate an extracellular gadolinium contrast agent, gadoteridol, for intracranial magnetic resonance (MR) angiography. The pre- and postcontrast MR angiograms of 82 patients were evaluated by the unblinded investigators and by two blinded readers (A and B) for visualization of lesions; arterial and venous anatomy; extent, size, and number of lesions; and disease classification. The unblinded readers indicated that lesions were visualized better on postcontrast images in the following categories: venous anatomy, 87 (81%) of 107 lesions; arterial anatomy, 43 lesions (40%); and extent or size of lesions, 38 lesions (36%). In 29 (35%) of 82 patients, the unblinded readers determined that enhanced MR angiography provided more diagnostic information than unenhanced MR angiography. The blinded readers determined that enhanced MR angiography provided more information for visualization of vascular anatomy in more than 60% of cases. The additional information provided with gadoteridol would have changed the diagnosis in nine (8%) of 107 lesions seen by the unblinded readers, 11 (12%) of 90 lesions seen by reader A, and three (3%) of 93 lesions seen by reader B. The results confirm that the use of gadoteridol improves the visualization of intracranial vascular lesions with MR angiography. The authors conclude that development of new postprocessing algorithms will improve the utility of contrast-enhanced MR angiography. 相似文献
10.